Statin Use May Improve Survival in Advanced Prostate Cancer
Statin use is associated with greater overall survival among men with metastatic castration-resistant prostate cancer and improved survival among patients with high-risk prostate cancer.
Diagnosis & Disease Information
Negative Repeat Biopsy in PCa Active Surveillance a Positive Sign
In a study, a negative confirmatory prostate biopsy in prostate cancer patients on active surveillance predicts a lower risk of progressing to treatment.
Earlier Prostate Cancer Drug Use in CRPC Cuts Metastasis Risk
In separate studies, apalutamide and enzalutamide prolonged metastasis-free survival in men with non-metastatic castration-resistant prostate cancer.
Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men
In a study of hypogonadal men, those who received testosterone therapy had a lower incidence of prostate cancer than those who did not.
- Loading...
Loading...
Next post in Genitourinary Cancers Symposium
Loading... 
Loading...